Phase III BALATON and COMINO studies of Vabysmo for people with retinal vein occlusion meet primary endpoints: Roche
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To find out more, see our Cookie Policy and Cookie Settings.Ok
